Systemic administration of rosmarinus officinalis attenuates the inflammatory response induced by carrageenan in the mouse model of pleurisy

Planta Medica

Volumn 79, Issue 17, 2013, Pages 1605-1614

  Da Rosa, Julia Salvan ^a   Facchin, Bruno Matheus ^a   Bastos, Juliana ^a   Siqueira, Mariana Araújo ^a   Micke, Gustavo Amadeu ^a   Dalmarco, Eduardo Monguilhott ^a   Pizzolatti, Moacir Geraldo ^a   Fröde, Tânia Silvia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

anti inflammatory effects; cytokines; Lamiaceae; mouse model of pleurisy; Rosmarinus officinalis

Indexed keywords

ACETIC ACID ETHYL ESTER; ADENOSINE DEAMINASE; ALCOHOL; CARNOSOL; CARRAGEENAN; DEXAMETHASONE; HEXANE; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; MYELOPEROXIDASE; NITRATE; NITRITE; ROSMARINIC ACID; ROSMARINUS OFFICINALIS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MOUSE; MOUSE MODEL; NONHUMAN; PLEURISY;

ADENOSINE DEAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CINNAMATES; CYTOKINES; DEPSIDES; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES; MICE; MICE, INBRED STRAINS; NITRATES; NITRITES; PEROXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLEURISY; RNA, MESSENGER; ROSMARINUS;

EID: 84889591370     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1351018     Document Type: Article

References (52)

1. Saklani A., Kutty S. K. Plant-derived compounds in clinical trials. Drug Discov Today: 2008; 13 161 171
2. Potterat O., Hamburger M. Drug discovery and development with plant-derived compounds. Prog Drug Res: 2008; 45 47 118
3. Gosslau A., Li S., Ho C., Chen K. Y., Rawson N. E. The importance of natural product characterization in studies of their anti-inflammatory activity. Mol Nutr Food Res: 2011; 55 74 82
4. Albuquerque U. P., Medeiros P. M., Almeida A. LS, Monteiro J. M., Neto E. MFL, Melo J. G., Santos J. P. Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: a quantitative approach. J Ethnopharmacol: 2007; 114 325 354 (Pubitemid 350030871)
5. Ulbricht C., Abrams T. R., Brigham A., Ceurvels J., Clubb J., Curtiss W., Kirkwood C. D., Giese N., Hoehn K., Iovin R., Isaac R., Rusie E., Serrano J. MG, Varghese M., Weissner W., Regina C., Windsor R. C. An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the Natural Standard Research Collaboration. J Diet Suppl: 2010; 7 351 413
6. Petersen M., Abdullah Y., Benner J., Eberle D., Gehlen K., Hücherig S., Janiak V., Kim K. H., Sander M., Weitzel C., Wolters S. Evolution of rosmarinic acid biosynthesis. Phytochemistry: 2009; 70 1663 1679
7. Ngo S. NT, Williams D. B., Head R. J. Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr: 2011; 51 946 954
8. Kontogianni A. VG, Tomic G., Nikolic I., Nerantzaki A. A., Sayyad N., Stosic-Grujicic S., Stojanovic I., Gerothanassis I. P., Tzakos A. G. Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem: 2013; 136 120 129
9. Bakirel T., Bakirel U., Keles O. U., Ulgen S. G., Yardibi H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Ethnopharmacol: 2008; 116 64 73
10. Machado D. G., Bettio L. EB, Cunha M. P., Capra J. C., Dalmarco J. B., Pizzolatti M. G., Rodrigues A. LS. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry: 2009; 33 642 650
11. Ibarra A., Cases J., Bily A., He K., Bai N., Roller M., Coussaert A., Ripoll C. Importance of extract standardization and in vitro/ex vivo assay selection for the evaluation of antioxidant activity of botanicals: a case study on three Rosmarinus officinalis L. extracts. J Med Food: 2010; 13 1167 1175
12. González-Trujano M. E., Peña E. I., Martínez A. L., Moreno J., Guevara-Fefer P., Déciga-Campos M., López-Muñoz F. J. Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents. J Ethnopharmacol: 2007; 111 476 482 (Pubitemid 46656210)
13. Takaki I., Bersani-Amado L. E., Vendruscolo A., Sartoretto S. M., Diniz S. P., Bersani-Amado C. A., Cuman R. K. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food: 2008; 11 741 746
14. Tai J., Cheung S., Wu M., Hasman D. Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Phytomedicine: 2012; 19 436 443
15. Ventura-Martínez R., Rivero-Osorno O., Gómez C., González-Trujano M. E. Spasmolytic activity of Rosmarinus officinalis L. involves calcium channels in the guinea pig ileum. J Ethnopharmacol: 2011; 137 1528 1532
16. Amin A., Hamza A. A. Hepatoprotective effects of Hibiscus, Rosmarinus, and Salvia on azathioprine-induced toxicity in rats. Life Sci: 2005; 77 266 278 (Pubitemid 40692867)
17. Park S. E., Kim S., Sapkota K., Kim S. J. Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y. Cell Mol Neurobiol: 2010; 30 759 767
18. Altinier G., Sosa S., Aquino R. P., Mencherini T., Della L. R., Tubaro A. Characterization of topical anti-inflammatory compounds in Rosmarinus officinalis L. J Agric Food Chem: 2007; 55 1718 1723 (Pubitemid 46479575)
19. Benincá J. P., Dalmarco J. B., Pizzolatti M. G., Fröde T. S. Analysis of the anti-inflammatory properties of Rosmarinus officinalis L. in mice. Food Chem: 2011; 124 468 475
20. Mengoni E. S., Vichera G., Rigano L. A., Rodriguez-Puebla M. L., Galliano S. R., Cafferata E. E., Pivetta O. H., Moreno S., Vojnov A. A. Suppression of COX-2, IL-1 β and TNF- α expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia: 2011; 82 414 421
21. Fröde T. S., Medeiros Y. S. Myeloperoxidase and adenosinedeaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm: 2001; 10 223 227 (Pubitemid 32846112)
22. Malle E., Furtmüller P. G., Satttler W., Obinger C. Myeloperoxidase: a target for new drug development? Br J of Pharmacol: 2007; 152 838 854 (Pubitemid 350100486)
23. Van Der Veen B. S., Winther M. PJ, Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal: 2009; 11 1 39
24. Arnhold J., Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys: 2010; 500 92 106
25. Lau D., Mollnau H., Eiserich J. P., Freeman B. A., Daiber A., Gehling U. M., Brümer J., Rudolph V., Münzel T., Heitzer T., Meinrtz T., Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD 11b/CD18 integrins. Proc Nat Acad Sci USA: 2005; 102 431 436 (Pubitemid 40116784)
26. Haegens A., Heeringa P., Van Suylen R. J., Steele C., Aratani Y., OÊDonoghue R. JJ, Mutsaers S. E., Mossman B. T., Wouters E. FM, Vernooy J. HJ. Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production. J Immunol: 2009; 182 7990 7996
27. Faith M., Sukumaran A., Pulimood A. B., Jacob M. How reliable an indicator of inflammation is myeloperoxidase activity? Clin Chim Acta: 2008; 396 23 25
28. Ekmekci O. B., Donma O., Sardoǧan E., Yildirim N., Uysal O., Demirel H., Demir T. Iron, nitric oxide, and myeloperoxidase in asthmatic patients. Biochemistry (Moscow): 2004; 69 462 467
29. Telles R. W., Ferreira G. A., Da Silva N. P., Sato E. I. Increased plasma myeloperoxidase levels in systemic lupus erythematosus. Rheumatol Int: 2010; 30 779 784
30. Kuno M., Seki N., Tsujimoto S., Nakanishi I., Kinoshita T., Nakamura K., Terasaka T., Nishio N., Sato A., Fujii T. Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. Eur J Pharmacol: 2006; 534 241 249 (Pubitemid 43384207)
31. Haskó G., Pacher P., Deitch E. A., Vizi E. S. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther: 2007; 113 264 275 (Pubitemid 46149045)
32. Krenke R., Korczyński P. Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med: 2010; 16 367 375
33. Sun C. X., Young H. W., Molina J. G., Volmer J. B., Schenermann J., Blackburn M. R. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest: 2005; 115 35 43 (Pubitemid 40385503)
34. Delano D. L., Montesinos M. C., Desai A., Wilder T., Fernandez P., DÊeustachio P., Wiltshire T., Cronstein B. N. Genetically-based resitance to the anti-inflammatory effects of methotrexate in the air pouch model of acute inflammation. Arthritis Rheum: 2005; 52 2567 2575 (Pubitemid 41117447)
35. Nakamachi Y., Koshiba M., Nakazawa T., Hatachi S., Saura R., Kurosaka M., Kusaka H., Kumagai S. Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts. Arthritis Rheum: 2003; 48 668 674 (Pubitemid 36302002)
36. Redington A. E. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Eur J Pharmacol: 2006; 533 263 276 (Pubitemid 43340018)
37. Sakaguchi Y., Shirahase H., Kunishiro K., Ichikawa A., Kanda M., Uehara Y. Effect of combination of nitric oxide synthase and cyclooxygenase inhibitors on carrageenan-induced pleurisy in rats. Life Sci: 2006; 79 442 447 (Pubitemid 43866125)
38. Chen H., Bai H., Xi M., Liu R., Qin X., Liang X., Zhang W., Zhang X., Li W., Hai C. Ethyl pyruvate protects rats from phosgene induced pulmonary edema by inhibiting cyclooxygenase2 and inducible nitric oxide synthase expression. J Appl Toxicol: 2013; 33 71 77
39. Park S. J., Lee Y. C. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res: 2010; 11 1 8
40. Wang Y., Liu Y. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol: 2008; 20 697 702
41. Herbert C., Hettiaratchi A., Webb D. C., Thomas P. S., Foster P. S., Kumar R. K. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clin Exp Allergy: 2008; 38 847 856 (Pubitemid 351550666)
42. Saraiva M., OÊGarra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol: 2010; 10 170 181
43. Ouyang W., Rutz S., Crellin N. K., Valdez P. A., Hymowitz S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol: 2011; 29 71 109
44. Nabe T., Ikedo A., Hosokawa F., Kishima M., Fujii M., Mizutani N., Yoshino S., Ishihara K., Akiba S., Chaplin D. D. Regulatory role of antigen-induced interleukin-10, produced by CD4+ T cells, in airway neutrophilia in a murine model for asthma. Eur J Pharmacol: 2012; 677 154 162
45. Tsumbu C. N., Deby-Dupont G., Tits M., Angenot L., Frederich M., Kohnen S., Mouithys-Mickalad A., Serteyn D., Franck T. Polyphenol content and modulatory activities of some tropical dietary plant extracts on the oxidant activities of neutrophils and myeloperoxidase. Int J Mol Sci: 2012; 13 628 650
46. Costa R. S., Carneiro T. CB, Cerqueira-Lima A. T., Queiroz N. V., Alcântara-Neves N. M., Pontes-De-Carvalho L. C., Velozo E. S., Oliveira E. J., Figueiredo C. A. Ocimum gratissimum Linn. and rosmarinic acid, attenuate eosinophilic airway inflammation in an experimental model of respiratory allergy to Blomia tropicalis. Int Immunopharmacol: 2012; 13 126 134
47. Johnson J. J. Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett: 2011; 305 1 7
48. Saleh T. S., Calixto J. B., Medeiros Y. S. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br J Pharmacol: 1996; 118 811 819 (Pubitemid 26180999)
49. Rao T. S., Currie J. L., Shaffer A. F., Isakson P. C. Comparative evaluation of arachidonic acid (AA)-and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation: 1993; 17 723 741 (Pubitemid 23359094)
50. Giusti G., Galanti B. Adenosine deamisase: colorimetric method. In: Bergmeyer H. U. editor Methods of enzymatic analysis. Weinheim Verlag Chemie Press: 1984; 315 323
51. 15 N] nitrate in biological fluids. Anal Biochem: 1982; 126 131 138 (Pubitemid 13203451)
52. Dalmarco E. M., Astolfi G., Liz R., Córdova C. MM, Fröde T. S. Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model. Int Immunopharmacol: 2012; 13 476 482